Cargando…

Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy

PURPOSE: Several international committees involved in establishing standards of care have recommended that patients undergoing surgery for bladder outlet obstruction should be assessed with patient reported outcomes (PRO). The Patient Global Impression of Improvement (PGI-I) is an instrument designe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossack, Tania, Woo, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society (APPS) 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286730/
https://www.ncbi.nlm.nih.gov/pubmed/25599074
http://dx.doi.org/10.12954/PI.14066
_version_ 1782351693742080000
author Hossack, Tania
Woo, Henry
author_facet Hossack, Tania
Woo, Henry
author_sort Hossack, Tania
collection PubMed
description PURPOSE: Several international committees involved in establishing standards of care have recommended that patients undergoing surgery for bladder outlet obstruction should be assessed with patient reported outcomes (PRO). The Patient Global Impression of Improvement (PGI-I) is an instrument designed to measure a patients interpretation of symptom changes following intervention. The objective of this study was to validate the PGI-I as a PRO assessment following surgery for bladder outflow obstruction (BOO) in men with benign prostatic hyperplasia (BPH). METHODS: Men undergoing photoselective vaporisation of the prostate were followed prospectively. Pre- and postoperative International Prostate Symptom Score (IPSS), Quality of life (QoL) index, peak urinary flow (Qmax), and postvoid residual (PVR) assessments were done. The PGI-I was conducted and correlated at 3 months postoperatively to changes in IPSS, QoL, Qmax, and PVR. RESULTS: One hundred and sixty-six consecutive patients were included. Following surgery, IPSS and QoL improved by 11 and 2.4 points (P<0.0001). PGI-I was found to correlate with postoperative changes in IPSS and QoL (Pearson correlation, 0.47 and 0.58, respectively; P<0.0001). CONCLUSIONS: This is the first study to validate the PGI-I as a PRO measure to surgery for BOO. This suggests a potential for the PGI-I to be used to assess surgical therapies for BPH and may be a valuable addition for measuring outcomes in clinical trials evaluating surgical interventions for BPH.
format Online
Article
Text
id pubmed-4286730
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Asian Pacific Prostate Society (APPS)
record_format MEDLINE/PubMed
spelling pubmed-42867302015-01-16 Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy Hossack, Tania Woo, Henry Prostate Int Original Article PURPOSE: Several international committees involved in establishing standards of care have recommended that patients undergoing surgery for bladder outlet obstruction should be assessed with patient reported outcomes (PRO). The Patient Global Impression of Improvement (PGI-I) is an instrument designed to measure a patients interpretation of symptom changes following intervention. The objective of this study was to validate the PGI-I as a PRO assessment following surgery for bladder outflow obstruction (BOO) in men with benign prostatic hyperplasia (BPH). METHODS: Men undergoing photoselective vaporisation of the prostate were followed prospectively. Pre- and postoperative International Prostate Symptom Score (IPSS), Quality of life (QoL) index, peak urinary flow (Qmax), and postvoid residual (PVR) assessments were done. The PGI-I was conducted and correlated at 3 months postoperatively to changes in IPSS, QoL, Qmax, and PVR. RESULTS: One hundred and sixty-six consecutive patients were included. Following surgery, IPSS and QoL improved by 11 and 2.4 points (P<0.0001). PGI-I was found to correlate with postoperative changes in IPSS and QoL (Pearson correlation, 0.47 and 0.58, respectively; P<0.0001). CONCLUSIONS: This is the first study to validate the PGI-I as a PRO measure to surgery for BOO. This suggests a potential for the PGI-I to be used to assess surgical therapies for BPH and may be a valuable addition for measuring outcomes in clinical trials evaluating surgical interventions for BPH. Asian Pacific Prostate Society (APPS) 2014-12 2014-12-30 /pmc/articles/PMC4286730/ /pubmed/25599074 http://dx.doi.org/10.12954/PI.14066 Text en Copyright © 2014 Asian Pacific Prostate Society (APPS)
spellingShingle Original Article
Hossack, Tania
Woo, Henry
Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy
title Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy
title_full Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy
title_fullStr Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy
title_full_unstemmed Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy
title_short Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy
title_sort validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286730/
https://www.ncbi.nlm.nih.gov/pubmed/25599074
http://dx.doi.org/10.12954/PI.14066
work_keys_str_mv AT hossacktania validationofapatientreportedoutcomequestionnaireforassessingsuccessofendoscopicprostatectomy
AT woohenry validationofapatientreportedoutcomequestionnaireforassessingsuccessofendoscopicprostatectomy